LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Point of care tobacco treatment sustains during COVID-19, a global pandemic.

Craig, Ethan J / Ramsey, Alex T / Baker, Timothy B / James, Aimee S / Luke, Douglas A / Malone, Sara / Chen, Jingling / Pham, Giang / Smock, Nina / Goldberg, Paula / Govindan, Ramaswamy / Bierut, Laura J / Chen, Li-Shiun

Cancer epidemiology

2021  Volume 78, Page(s) 102005

Abstract: ... comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled ... EHR-enabled tobacco treatment care model demonstrates sustained reach up to 30 months following ... tobacco treatment care model, reach of treatment increased from pre to post T5 (3.2 % vs. 48.4 %, RR 15.50 ...

Abstract Background: Tobacco cessation treatment for cancer patients is essential to providing comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled by electronic health record (EHR) modifications in a comprehensive cancer center. Data are needed on the sustainability of both reach of treatment and effectiveness over time, including the COVID-19 pandemic.
Methods: Using EHR data from the pre-implementation (P: 5 months) and post-implementation periods (6 month-blocks, T1-T5 for a total of 30 months), we compared two primary outcomes: 1) reach of treatment among those smoking and 2) effectiveness assessed by smoking cessation among those smoking in the subsequent 6 month period. We analyzed the data using generalized estimation equation regression models.
Results: With the point of care tobacco treatment care model, reach of treatment increased from pre to post T5 (3.2 % vs. 48.4 %, RR 15.50, 95 % CI 10.56-22.74, p < 0.0001). Reach of treatment in all post periods (T1-T5 including the COVID-19 pandemic time) remained significantly higher than the pre period. Effectiveness, defined by smoking cessation among those smoking, increased from pre to post T2 before the pandemic (12.4 % vs. 21.4 %, RR 1.57, 95 % CI 1.31-1.87, p < 0.0001). However, effectiveness, while higher in later post periods (T3, T4), was no longer significantly increased compared with the pre period.
Conclusion: A point of care EHR-enabled tobacco treatment care model demonstrates sustained reach up to 30 months following implementation, even during the COVID-19 pandemic and changes in healthcare prioritization. Effectiveness was sustained for 12 months, but did not sustain through the subsequent 12 months.
MeSH term(s) COVID-19/epidemiology ; Humans ; Pandemics ; Point-of-Care Systems ; Smoking Cessation ; Nicotiana
Language English
Publishing date 2021-08-18
Publishing country Netherlands
Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID 2508729-0
ISSN 1877-783X ; 1877-7821
ISSN (online) 1877-783X
ISSN 1877-7821
DOI 10.1016/j.canep.2021.102005
Shelf mark
Zs.A 1427: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top